T‐Wave Alternans, Heart Rate Turbulence, and Ventricular Ectopy in Standard versus Daily Hemodialysis: Results from the FHN Daily Trial

Hemodialysis (HD) patients are at high risk of sudden cardiac death (SCD). HD 6‐times/week (6x/wk) may reduce SCD risk compared to usual 3‐times/week HD (3x/wk) by mechanisms unknown. T‐wave alternans (TWA), heart rate turbulence (HRT), and ventricular ectopy (VE) are elevated in HD patients, but their response to 6x/wk HD has not been assessed.

[1]  G. Schmidt,et al.  Heart Rate Turbulence to Guide Treatment for Prevention of Sudden Death , 2010, Journal of cardiovascular pharmacology.

[2]  G. Beck,et al.  Frequent Hemodialysis Network (FHN) randomized trials: study design. , 2007, Kidney international.

[3]  Rod Passman,et al.  Prevention of Sudden Cardiac Death in Dialysis Patients: Drugs, Defibrillators or What Else? , 2013, Blood Purification.

[4]  J. Camm,et al.  T-wave alternans and left ventricular wall thickness in predicting arrhythmic risk in patients with hypertrophic cardiomyopathy. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[5]  Tom H Greene,et al.  Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  Takanori Ikeda,et al.  Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study. , 2009, Heart rhythm.

[7]  G. Beck,et al.  In-center hemodialysis six times per week versus three times per week. , 2010, The New England journal of medicine.

[8]  Rod Passman,et al.  High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. , 2011, Heart rhythm.

[9]  T. Ikeda,et al.  Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications. , 2013, Progress in cardiovascular diseases.

[10]  Rajan K. Patel,et al.  Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[11]  Federico Lombardi,et al.  Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. , 2008, Journal of the American College of Cardiology.

[12]  Juan Pablo Martínez,et al.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. , 2011, Journal of the American College of Cardiology.

[13]  R. Passman,et al.  NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients , 2008, Seminars in dialysis.

[14]  A. Camm,et al.  Dialysis‐Dependent Changes in Ventricular Repolarization , 2012, Pacing and clinical electrophysiology : PACE.

[15]  J. Bigger,et al.  Ambulatory Electrocardiogram‐Based Tracking of T Wave Alternans in Postmyocardial Infarction Patients to Assess Risk of Cardiac Arrest or Arrhythmic Death , 2003, Journal of cardiovascular electrophysiology.